Participated · Seed · Mar 2026

VerbaFlo provides a purpose-built AI communications layer for residential real estate, deploying specialised AI agents across leasing, marketing, operations, and maintenance and integrating with existing property systems. The platform centralises conversations across email, web chat, messaging apps, and phone to enable real-time, multilingual engagement at scale. VerbaFlo aims to improve response times, increase conversion rates, and reduce operational workload for property operators. The company currently supports more than 200,000 units globally and has grown across the UK and Europe with recent expansion into the United States. Founded in 2024, VerbaFlo plans further international rollouts and continued product development funded by its recent seed raise. Its commercial positioning emphasises vertical-specific AI automation rather than general chatbot solutions.

Participated · Series B · Oct 2023

Optimize Health is a Seattle-based provider of a remote patient monitoring and chronic care management software platform. Led by CEO Todd Haedrich, the company’s platform helps healthcare providers improve patient outcomes, enhance clinical decision-making, and optimize operational efficiency. Its technology assists physicians in preventing episodic events, delivering personalized care plans, and enabling clinical teams to practice proactive medicine by sharing patient data and insights. The platform also empowers patients with visibility into their health metrics to increase engagement. Thousands of healthcare providers have used the software to drive down costs and create better outcomes. The company plans to use new funding to accelerate market strategy, scale operations, expand its product portfolio, and fuel market expansion. Optimize Health recently closed an $18M Series B financing. Founded in 2015 and based in Seattle, Optimize.health offers an end-to-end remote patient monitoring service used by independent practices and hospital systems. The platform ingests data from home devices such as blood pressure cuffs and pulse oximeters, surfaces potential issues on a clinician dashboard, integrates with EHRs, and supports outreach via texts and video calls. The dashboard can trigger billing to insurers for clinician monitoring. The company shifted from its prior Pillsy smart pill-bottle product to a broader remote-monitoring strategy. Optimize.health is capitalizing on a recent Medicare policy change that allows providers to bill for remote monitoring and on increased attention to telemedicine amid the pandemic. Revenue recently grew more than 800% year-over-year; the company employs fewer than 30 people and has raised over $21 million to date. optimize.health offers a technology platform that enables healthcare providers to deliver patient-centric, reimbursable remote monitoring using a wide selection of integrated, affordable devices. The solution integrates device data with the company’s platform to help patients and providers improve health outcomes and contain costs. The company plans to use new funding to build out platform capabilities and integrate additional data sources, and to expand its sales and marketing teams. optimize.health was established in 2019 by Jeff LeBrun and Chuks Onwuneme and is based in Seattle with additional employees in Phoenix, Houston and Charlotte, NC. Its team and advisors include clinicians, software engineers, designers and data scientists with backgrounds at Google, Microsoft, Apple, Facebook, Amazon, Novartis, Duke University and the Institute for Health Metrics.

Participated · Series B · Dec 2022

Stellar is a technology-driven marketplace that enables property managers and contractors to resolve home maintenance issues across the single-family rental (SFR) market. The platform leverages artificial intelligence and machine learning to make maintenance fast, scalable, and quality-guaranteed. The company serves 10 of the 11 largest SFR operators across 150,000+ properties, has created work for 8,000+ contractors, and has resolved 200,000+ issues. Stellar plans to use its Series B proceeds to enhance its technology and platform, build a new mobile app, invest in talent, and expand into additional U.S. markets. It intends to nearly double headcount by the end of 2023 across Operations, Sales, Marketing, and Technology, and recently appointed Renaud Casanova as CTO. Founded in 2016 and based in Dallas, the company has raised $35M in total venture capital to date.

Participated · Seed · Nov 2022

Valarian Technologies develops ACRA, a software layer described as a sealed operating room for AI workloads and sensitive applications that controls what data leaves systems, who can access it, and who can shut it off. The product is positioned to let governments and enterprises retain control while still using major cloud providers by enforcing policy and access controls outside those providers’ native stack. The company was founded and is led by Max Buchan, with co-founder Josh McLaughlin joining from a senior role at Palantir, and is based in London. Valarian’s positioning responds to geopolitical risks such as the U.S. CLOUD Act and recent restrictions on access to U.S.-based AI services. Financially, the company has raised $70 million to date, including a $50 million Series A led by NEA.

Participated · Series B · Feb 2022

Fama is a Los Angeles-based social media screening company applying AI to background screening services. Led by CEO Ben Mones, its solutions are used by enterprise HR and Talent leaders at more than 1,500 businesses in 32 countries. The product helps identify candidate behaviors such as intolerance and harassment that are often missed in the hiring process. Fama plans to use the new funds to expand its partnerships team, drive more awareness about its solutions, and develop new products for its clients. The company also intends to deepen relationships with its existing resale network to generate additional revenue streams for background screening firms, applicant tracking systems, and other HCM software providers.